Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Erratum to: An Integrative Analysis of microRNA and mRNA Profiling in CML Stem Cells.
Methods Mol Biol. 2016;1465:E1. doi: 10.1007/978-1-4939-4011-0_20.
Methods Mol Biol. 2016.
PMID: 28116664
No abstract available.
An Integrative Analysis of microRNA and mRNA Profiling in CML Stem Cells.
Nassar FJ, El Eit R, Nasr R.
Nassar FJ, et al. Among authors: el eit r.
Methods Mol Biol. 2016;1465:219-41. doi: 10.1007/978-1-4939-4011-0_18.
Methods Mol Biol. 2016.
PMID: 27581151
Item in Clipboard
Antitumor efficacy of arsenic/interferon in preclinical models of chronic myeloid leukemia resistant to tyrosine kinase inhibitors.
El Eit R, Itani AR, Nassar F, Rasbieh N, Jabbour M, Santina A, Zaatari G, Mahon FX, Bazarbachi A, Nasr R.
El Eit R, et al.
Cancer. 2019 Aug 15;125(16):2818-2828. doi: 10.1002/cncr.32130. Epub 2019 Apr 29.
Cancer. 2019.
PMID: 31034603
Free article.
Item in Clipboard
EAPB0503, a novel imidazoquinoxaline derivative, inhibits growth and induces apoptosis in chronic myeloid leukemia cells.
Saliba J, Deleuze-Masquéfa C, Iskandarani A, El Eit R, Hmadi R, Mahon FX, Bazarbachi A, Bonnet PA, Nasr R.
Saliba J, et al. Among authors: el eit r.
Anticancer Drugs. 2014 Jul;25(6):624-32. doi: 10.1097/CAD.0000000000000084.
Anticancer Drugs. 2014.
PMID: 24463483
Item in Clipboard
Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alpha.
El Eit RM, Iskandarani AN, Saliba JL, Jabbour MN, Mahfouz RA, Bitar NM, Ayoubi HR, Zaatari GS, Mahon FX, De Thé HB, Bazarbachi AA, Nasr RR.
El Eit RM, et al.
Int J Cancer. 2014 Feb 15;134(4):988-96. doi: 10.1002/ijc.28427. Epub 2013 Sep 10.
Int J Cancer. 2014.
PMID: 23934954
Item in Clipboard
ST1926, an orally active synthetic retinoid, induces apoptosis in chronic myeloid leukemia cells and prolongs survival in a murine model.
Nasr RR, Hmadi RA, El-Eit RM, Iskandarani AN, Jabbour MN, Zaatari GS, Mahon FX, Pisano CC, Darwiche ND.
Nasr RR, et al. Among authors: el eit rm.
Int J Cancer. 2015 Aug 1;137(3):698-709. doi: 10.1002/ijc.29407. Epub 2015 Jan 21.
Int J Cancer. 2015.
PMID: 25557649
Item in Clipboard
The synthetic retinoid ST1926 as a novel therapeutic agent in rhabdomyosarcoma.
Basma H, Ghayad SE, Rammal G, Mancinelli A, Harajly M, Ghamloush F, Dweik L, El-Eit R, Zalzali H, Rabeh W, Pisano C, Darwiche N, Saab R.
Basma H, et al. Among authors: el eit r.
Int J Cancer. 2016 Mar 15;138(6):1528-37. doi: 10.1002/ijc.29886. Epub 2015 Oct 22.
Int J Cancer. 2016.
PMID: 26453552
Item in Clipboard
Cite
Cite